Dr Shefali Rajpopat, MBBS(Hons), BSc(Hons), MRCP
Clinical Senior Lecturer & Honorary Consultant Dermatologist
Email: email@example.comTelephone: 020 7882 8789
Shefali Rajpopat qualified from Guy’s, King’s and St Thomas’ medical school in 1999. She trained in Dermatology at Barts and The London and the Royal Free NHS Trusts and at St John’s Institute of Dermatology. In 2010 she was appointed Clinical Senior Lecturer at the Centre for Cutaneous Research and Honorary Consultant in Dermatology at Whipps Cross University Hospital. She is a course Director for the International Postgraduate Diploma in Clinical Dermatology.
Through the International Diploma in Clinical Dermatology, Shefali is involved in a web-based, distance learning postgraduate medical education programme. She also participates in undergraduate teaching at QMUL and postgraduate teaching in Primary Care.
Recent and ongoing research projects:
Shefali spent 2 years at the Centre for Cutaneous Research working with Professor David Kelsell and Professor Edel O’Toole on harlequin ichthyosis. She has an ongoing academic interest in medical education and is a course Director for the International Diploma in Clinical Dermatology.
Blaydon DC, Nitoiu D, Eckl KM, Cabral RM, Bland P, Hausser I, van Heel DA, Rajpopat S, Fischer J, Oji V, Zvulunov A, Traupe H, Hennies HC, Kelsell DP. Mutations in CSTA, Encoding Cystatin A, Underlie Exfoliative Ichthyosis and Reveal a Role for This Protease Inhibitor in Cell-Cell Adhesion. Am J Hum Genet. Epub 2011 Sep 22.
Rajpopat S, Moss C, Mellerio JE, Vahlquist A, Ganemo A, Hellstrom-Pigg M, Ilchyshyn A, Burrows NP, Lestringent G, Taylor AE, Kennedy CT, Paige DG, Harper JI, Glover M, Fleckman P, Everman D, Fouani MH, Kayserili H, Purvis DJ, Hobson E, Chu C, Mein CA, Kelsell DP, O’Toole EA. Harlequin ichthyosis: a review of 45 cases. Arch Dermatol. 2011 Jun; 147(6): 681-6.
Rajpopat S, Karim A, Barker J. Linear lichen aureus. Retinoids 2004; 20(2): 47-49.
Stebbing J, Atkins M, Nelson M, Rajpopat S, Newsom-Davis T, Gazzard B, Bower M. Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome. Blood. 2004 Mar 15; 103(6): 2431-2.